CSP1.L vs. NOV.DE

Last updated Jun 5, 2026

CSP1.L (iShares Core S&P 500 UCITS ETF) is S&P 500 fund tracking the S&P 500 Index, while NOV.DE (Novo Nordisk A/S) is a stock. Over the past 10 years, CSP1.L returned 16.07%/yr vs 10.69%/yr for NOV.DE. At a 0.33 correlation, their price movements are largely independent.

Performance

CSP1.L vs. NOV.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in iShares Core S&P 500 UCITS ETF (CSP1.L) and Novo Nordisk A/S (NOV.DE). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CSP1.L is traded in GBp, while NOV.DE is traded in EUR. To make them comparable, the NOV.DE values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, CSP1.L achieves a 10.55% return, which is significantly higher than NOV.DE's -11.27% return. Over the past 10 years, CSP1.L has outperformed NOV.DE with an annualized return of 16.07%, while NOV.DE has yielded a comparatively lower 10.69% annualized return.

CSP1.L

• 1D: 0.05%
• 1M: 5.54%
• YTD: 10.55%
• 6M: 10.48%
• 1Y: 29.13%
• 3Y*: 19.02%
• 5Y*: 14.94%
• 10Y*: 16.07%

NOV.DE

• 1D: 4.39%
• 1M: -0.12%
• YTD: -11.27%
• 6M: -4.93%
• 1Y: -35.94%
• 3Y*: -17.46%
• 5Y*: 5.25%
• 10Y*: 10.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CSP1.L vs. NOV.DE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CSP1.L iShares Core S&P 500 UCITS ETF	10.55%	9.37%	27.35%	19.79%	-9.05%	31.07%	13.65%	26.42%	0.01%	10.83%
NOV.DE Novo Nordisk A/S	-11.27%	-43.10%	-13.69%	46.60%	37.72%	61.40%	19.73%	28.35%	21.15%	40.67%

Correlation

The correlation between CSP1.L and NOV.DE is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.25
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.32
Correlation (All Time) Calculated using the full available price history since Sep 16, 2010	0.33

Return for Risk

CSP1.L vs. NOV.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CSP1.L

CSP1.L Risk / Return Rank: 82
CSP1.L Sharpe Ratio Rank: 84
CSP1.L Sortino Ratio Rank: 83
CSP1.L Omega Ratio Rank: 85
CSP1.L Calmar Ratio Rank: 80
CSP1.L Martin Ratio Rank: 78

NOV.DE

NOV.DE Risk / Return Rank: 16
NOV.DE Sharpe Ratio Rank: 12
NOV.DE Sortino Ratio Rank: 15
NOV.DE Omega Ratio Rank: 14
NOV.DE Calmar Ratio Rank: 17
NOV.DE Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CSP1.L vs. NOV.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Core S&P 500 UCITS ETF (CSP1.L) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CSP1.L	NOV.DE	Difference
Sharpe ratio: Return per unit of total volatility	2.73	-0.67	+3.40
Sortino ratio: Return per unit of downside risk	3.66	-0.69	+4.35
Omega ratio: Gain probability vs. loss probability	1.51	0.90	+0.61
Calmar ratio: Return relative to maximum drawdown	4.07	-0.67	+4.74
Martin ratio: Return relative to average drawdown	14.99	-1.01	+16.00
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CSP1.L vs. NOV.DE - Sharpe Ratio Comparison

The current CSP1.L Sharpe Ratio is 2.73, which is higher than the NOV.DE Sharpe Ratio of -0.67. The chart below compares the historical Sharpe Ratios of CSP1.L and NOV.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CSP1.L	NOV.DE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.73	-0.67	+3.40
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.04	0.14	+0.91
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	1.03	0.32	+0.71
Sharpe Ratio (All Time) Calculated using the full available price history	1.09	0.55	+0.54

Drawdowns

CSP1.L vs. NOV.DE - Drawdown Comparison

The maximum CSP1.L drawdown since its inception was -25.48%, smaller than the maximum NOV.DE drawdown of -75.95%. Use the drawdown chart below to compare losses from any high point for CSP1.L and NOV.DE.

Drawdown Indicators

	CSP1.L	NOV.DE	Difference
Max Drawdown Largest peak-to-trough decline	-25.48%	-75.95%	+50.47%
Max Drawdown (1Y) Largest decline over 1 year	-7.12%	-53.54%	+46.42%
Max Drawdown (3Y) Largest decline over 3 years	-20.77%	-75.95%	+55.18%
Max Drawdown (5Y) Largest decline over 5 years	-20.77%	-75.95%	+55.18%
Max Drawdown (10Y) Largest decline over 10 years	-25.48%	-75.95%	+50.47%
Current Drawdown Current decline from peak	-0.24%	-69.83%	+69.59%
Average Drawdown Average peak-to-trough decline	-3.32%	-11.40%	+8.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.94%	35.69%	-33.75%

Volatility

CSP1.L vs. NOV.DE - Volatility Comparison

The current volatility for iShares Core S&P 500 UCITS ETF (CSP1.L) is 2.62%, while Novo Nordisk A/S (NOV.DE) has a volatility of 8.69%. This indicates that CSP1.L experiences smaller price fluctuations and is considered to be less risky than NOV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CSP1.L	NOV.DE	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.62%	8.69%	-6.07%
Volatility (6M) Calculated over the trailing 6-month period	7.16%	39.33%	-32.17%
Volatility (1Y) Calculated over the trailing 1-year period	10.62%	53.41%	-42.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.31%	37.96%	-23.65%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	15.57%	33.68%	-18.11%

Dividends

CSP1.L vs. NOV.DE - Dividend Comparison

CSP1.L has not paid dividends to shareholders, while NOV.DE's dividend yield for the trailing twelve months is around 4.11%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CSP1.L iShares Core S&P 500 UCITS ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOV.DE Novo Nordisk A/S	4.11%	3.54%	1.58%	1.01%	1.17%	1.27%	1.98%	2.08%	27.19%	2.27%	3.67%	1.25%

Frequently Asked Questions

Can I hold both CSP1.L and NOV.DE in my portfolio?

CSP1.L and NOV.DE have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.